Similar effects was described in an animal model of cancer, in which IDO-based vaccination significantly enhanced immune responses against other tumor antigen–specific vaccines by downregulating IDO-expressing cell numbers in the TME [74]. This evidence concerns the gene IDO1 and cancer.